Abu Dhabi: Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) and Infinite Brain Technologies (IBT) have entered a five-year research and development agreement. According to the agreement, the two industry thought leaders will form a joint research lab to develop precise, personalised Digital Therapeutics (DTx) for human brain health by optimising the power of artificial intelligence technologies.
Together, MBZUAI and IBT aim to explore the unknown areas of brain science and push the boundaries of mental health intervention.
The collaboration seeks to capitalise on IBT’s capacity in the development and commercialization of digital therapeutics alongside MBZUAI’s expertise in artificial intelligence, with the ultimate goal of realising powerful, personalised brain and mental disorder treatments.
According to Mr. Kun Zhang, MBZUAI Deputy Department Chair of Machine Learning and Director of the Centre for Integrative Artificial Intelligence, this new collaboration with IBT has the potential to significantly increase our understanding of brain health, ideally resulting in both physical and mental wellness benefits for patients.
Mr. Justin Jia, co-founder and CTO of IBT, commented that “at IBT, we have a strong data science and engineering team that is capable of designing, developing, deploying, and scaling digital solutions in a short period of time. We are excited to join forces with MBZUAI, and specifically, Dr. Kun Zhang’s team, to work on some of the most advanced topics in machine learning for brain science.”
Founder and Managing Director of (IBT Investor) MSA Capital, Ms. Jenny Zeng, remarked that “MSA Capital has supported these initiatives from their earliest days by bringing industry leading companies like IBT from China to Abu Dhabi where they encounter world-class infrastructure and partners driven by a visionary national strategic imperative for innovation.”